Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236545 · ClinicalTrials.gov registry record · NA
Menopause Effects on Vascular Function
A NA study of Cardiovascular Risk Factor, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT03236545 is a NA study of Cardiovascular Risk Factor that has completed, run by University of Delaware. The registered enrollment target is 48 participants, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03236545, a NA study of Cardiovascular Risk Factor, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to identify the independent effect of estradiol (E2) on endothelin-1 (ET-1) mediated vasomotor function in women. The study is the first step in recognizing the impact of ovarian hormones on the mechanisms that regulate vascular function in women to provide a better understanding of the cardiovascular efficacy of hormone therapy.
Conditions Studied
Interventions
- OTHER No to Low Endogenous Estrogen
- OTHER Estradiol
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236545
The ClinicalTrials.gov registry entry for NCT03236545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 2 interventions - of which No to Low Endogenous Estrogen is the first listed.
NCT03236545 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT03236545 about?
NCT03236545 is a clinical study titled "Menopause Effects on Vascular Function". The purpose of the study is to identify the independent effect of estradiol (E2) on endothelin-1 (ET-1) mediated vasomotor function in women. The study is the first step in recognizing the impact of ovarian hormones on the mechanisms that regulate vascular function in women to provide a better under...
What is the current status of trial NCT03236545?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2016-07-01. Estimated completion is 2022-11-01.
What conditions does trial NCT03236545 study?
This clinical trial studies the following conditions: Cardiovascular Risk Factor.
What interventions are being tested in trial NCT03236545?
The interventions under investigation include: No to Low Endogenous Estrogen (OTHER), Estradiol (OTHER).
Who is sponsoring clinical trial NCT03236545?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03236545 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Risk Factor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
Sleep Duration and Cardiovascular Health
RECRUITING · NA
-
The Potassium Supplementation Study
RECRUITING · NA
-
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
RECRUITING · NA
-
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.